Alzinova AB (publ) (ALZ.ST)

SEK 1.85

(0.0%)

EBITDA Summary of Alzinova AB (publ)

  • Alzinova AB (publ)'s latest annual EBITDA in 2023 was 41.99 Thousand SEK , down -25.36% from previous year.
  • Alzinova AB (publ)'s latest quarterly EBITDA in 2024 Q2 was -4.76 Million SEK , up 3.95% from previous quarter.
  • Alzinova AB (publ) reported an annual EBITDA of -13.06 Million SEK in 2022, down -73.8% from previous year.
  • Alzinova AB (publ) reported an annual EBITDA of -7.51 Million SEK in 2021, down -15.71% from previous year.
  • Alzinova AB (publ) reported a quarterly EBITDA of -4.76 Million SEK for 2024 Q2, up 3.95% from previous quarter.
  • Alzinova AB (publ) reported a quarterly EBITDA of -3.9 Million SEK for 2023 Q2, up 8.52% from previous quarter.

Annual EBITDA Chart of Alzinova AB (publ) (2023 - 2012)

Historical Annual EBITDA of Alzinova AB (publ) (2023 - 2012)

Year EBITDA EBITDA Growth
2023 41.99 Thousand SEK -25.36%
2022 -13.06 Million SEK -73.8%
2021 -7.51 Million SEK -15.71%
2020 -6.49 Million SEK -5.2%
2019 -6.17 Million SEK -47.93%
2018 903.00 SEK -67.71%
2017 -18.12 Thousand SEK 15.75%
2016 3009.00 SEK 13.2%
2015 -2421.00 SEK -28366.27%
2014 -11.96 Thousand SEK -234.11%
2013 -3580.00 SEK -141.18%
2012 8694.00 SEK 0.0%

Peer EBITDA Comparison of Alzinova AB (publ)

Name EBITDA EBITDA Difference
Calliditas Therapeutics AB (publ) -367.8 Million SEK 100.011%
Camurus AB (publ) 562.54 Million SEK 99.993%
Mendus AB (publ) -97.84 Million SEK 100.043%
Lipum AB (publ) -37.11 Million SEK 100.113%
NextCell Pharma AB -40.98 Million SEK 100.102%
Simris Alg AB (publ) -22.36 Million SEK 100.188%
Elicera Therapeutics AB (publ) -17.08 Million SEK 100.246%
Active Biotech AB (publ) -43.88 Million SEK 100.096%
Amniotics AB (publ) -27.14 Million SEK 100.155%
Asarina Pharma AB (publ) -14.21 Million SEK 100.295%
BioArctic AB (publ) 275.38 Million SEK 99.985%
Cantargia AB (publ) -284.31 Million SEK 100.015%
Scandinavian ChemoTech AB (publ) -19.57 Million SEK 100.215%
CombiGene AB (publ) -35.33 Million SEK 100.119%
Diamyd Medical AB (publ) -140.85 Million SEK 100.03%
Genovis AB (publ.) 64.57 Million SEK 99.935%
Guard Therapeutics International AB (publ) -114.9 Million SEK 100.037%
Isofol Medical AB (publ) -37.02 Million SEK 100.113%
Intervacc AB (publ) -68.98 Million SEK 100.061%
Kancera AB (publ) -61.88 Million SEK 100.068%
Karolinska Development AB (publ) -26.78 Million SEK 100.157%
LIDDS AB (publ) -39.67 Million SEK 100.106%
Lipigon Pharmaceuticals AB (publ) -12.1 Million SEK 100.347%
Magle Chemoswed Holding AB (publ) 31.4 Million SEK 99.866%
OncoZenge AB (publ) 7.26 Million SEK 99.422%
Saniona AB (publ) -69.69 Million SEK 100.06%
Vicore Pharma Holding AB (publ) -317.46 Million SEK 100.013%
Xbrane Biopharma AB (publ) -282.03 Million SEK 100.015%
Xintela AB (publ) -53.47 Million SEK 100.079%
Xspray Pharma AB (publ) -169.81 Million SEK 100.025%
Ziccum AB (publ) -20.34 Million SEK 100.206%
Modus Therapeutics Holding AB (publ) 2000.00 SEK -1999.95%
Alligator Bioscience AB (publ) -237.61 Million SEK 100.018%
Sprint Bioscience AB (publ) -2.08 Million SEK 102.019%
QuiaPEG Pharmaceuticals Holding AB (publ) -13.43 Million SEK 100.313%
Corline Biomedical AB -1.69 Million SEK 102.484%
IRLAB Therapeutics AB (publ) -173.32 Million SEK 100.024%
Bio-Works Technologies AB (publ) -54.8 Million SEK 100.077%
Aptahem AB (publ) -10 Million SEK 100.42%
Infant Bacterial Therapeutics AB (publ) 11.54 Million SEK 99.636%
Fluicell AB (publ) -25.91 Million SEK 100.162%
Biovica International AB (publ) -119.5 Million SEK 100.035%
Spago Nanomedical AB (publ) -42.22 Million SEK 100.099%
AcouSort AB (publ) -16.7 Million SEK 100.251%
Abliva AB (publ) -93.6 Million SEK 100.045%
Egetis Therapeutics AB (publ) -319.1 Million SEK 100.013%
2cureX AB (publ) -35.13 Million SEK 100.12%
I-Tech AB 30.34 Million SEK 99.862%
Hansa Biopharma AB (publ) -714.55 Million SEK 100.006%
Cyxone AB (publ) -20.41 Million SEK 100.206%
ExpreS2ion Biotech Holding AB (publ) -102.45 Million SEK 100.041%
Biosergen AB 228 Thousand SEK 81.579%
Nanologica AB (publ) -62.11 Million SEK 100.068%
SynAct Pharma AB -222.7 Million SEK 100.019%
Annexin Pharmaceuticals AB (publ) -43.86 Million SEK 100.096%
BioInvent International AB (publ) -312.7 Million SEK 100.013%
Stayble Therapeutics AB (publ) 309.41 Thousand SEK 86.426%
Oncopeptides AB (publ) -231.62 Million SEK 100.018%
Pila Pharma AB (publ) -8.81 Million SEK 100.477%
Ascelia Pharma AB (publ) -108.55 Million SEK 100.039%
Diagonal Bio AB (publ) -11.46 Million SEK 100.366%